BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11890746)

  • 1. Streptozotocin-pancreatic damage in the rat: modulatory effect of 15-deoxy delta12,14-prostaglandin j(2) on nitridergic and prostanoid pathway.
    González E; Jawerbaum A; Sinner D; Pustovrh C; White V; Capobianco E; Xaus C; Peralta C; Roselló-Catafau J
    Nitric Oxide; 2002 Mar; 6(2):214-20. PubMed ID: 11890746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of inducible isoforms of COX and NOS in streptozotocin-pancreatic damage in the rat: interactions between nitridergic and prostanoid pathway.
    González E; Roselló-Catafau J; Jawerbaum A; Vela J; Sinner D; Pustovrh C; White V; Xaus C; Peralta C; Gimeno MA
    Prostaglandins Leukot Essent Fatty Acids; 2001 Jun; 64(6):311-6. PubMed ID: 11427040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathway.
    Boyault S; Bianchi A; Moulin D; Morin S; Francois M; Netter P; Terlain B; Bordji K
    FEBS Lett; 2004 Aug; 572(1-3):33-40. PubMed ID: 15304320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint.
    Pena-dos-Santos DR; Severino FP; Pereira SA; Rodrigues DB; Cunha FQ; Vieira SM; Napimoga MH; Clemente-Napimoga JT
    Neuroscience; 2009 Nov; 163(4):1211-9. PubMed ID: 19647045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes.
    Sánchez-Gómez FJ; Cernuda-Morollón E; Stamatakis K; Pérez-Sala D
    Mol Pharmacol; 2004 Nov; 66(5):1349-58. PubMed ID: 15317873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism.
    Reyes-Martin P; Ramirez-Rubio S; Parra-Cid T; Bienes-Martínez R; Lucio-Cazana J
    Pharmacol Res; 2008 May; 57(5):344-50. PubMed ID: 18456507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 15-Deoxy-Delta12,14-prostaglandin J2 and peroxisome proliferator-activated receptor gamma (PPARgamma) levels in term placental tissues from control and diabetic rats: modulatory effects of a PPARgamma agonist on nitridergic and lipid placental metabolism.
    Capobianco E; Jawerbaum A; Romanini MC; White V; Pustovrh C; Higa R; Martinez N; Mugnaini MT; Soñez C; Gonzalez E
    Reprod Fertil Dev; 2005; 17(4):423-33. PubMed ID: 15899154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process.
    Cheron A; Peltier J; Perez J; Bellocq A; Fouqueray B; Baud L
    J Immunol; 2004 Jun; 172(12):7677-83. PubMed ID: 15187150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis.
    Badawi AF; Badr MZ
    Int J Cancer; 2003 Jan; 103(1):84-90. PubMed ID: 12455057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15d-prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor.
    Napimoga MH; Souza GR; Cunha TM; Ferrari LF; Clemente-Napimoga JT; Parada CA; Verri WA; Cunha FQ; Ferreira SH
    J Pharmacol Exp Ther; 2008 Jan; 324(1):313-21. PubMed ID: 17928570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages.
    Janabi N
    J Immunol; 2002 May; 168(9):4747-55. PubMed ID: 11971025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of IFN-gamma -induced STAT1 activation by 15- deoxy-Delta 12,14-prostaglandin J2.
    Weber SM; Scarim AL; Corbett JA
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E883-91. PubMed ID: 12517740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells.
    Bamba H; Ota S; Kato A; Kawamoto C; Fujiwara K
    Biochem Biophys Res Commun; 2000 Jul; 273(2):485-91. PubMed ID: 10873632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.
    Straus DS; Pascual G; Li M; Welch JS; Ricote M; Hsiang CH; Sengchanthalangsy LL; Ghosh G; Glass CK
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4844-9. PubMed ID: 10781090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of c-jun N-terminal kinase activation in 15-deoxy-delta12,14-prostaglandin J2-and prostaglandin A1-induced apoptosis in AGS gastric epithelial cells.
    Liu JD; Lin SY; Ho YS; Pan S; Hung LF; Tsai SH; Lin JK; Liang YC
    Mol Carcinog; 2003 May; 37(1):16-24. PubMed ID: 12720296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
    Jung WK; Park IS; Park SJ; Yea SS; Choi YH; Oh S; Park SG; Choi IW
    Life Sci; 2009 Jul; 85(1-2):46-53. PubMed ID: 19409914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes.
    Fionda C; Nappi F; Piccoli M; Frati L; Santoni A; Cippitelli M
    Mol Pharmacol; 2007 Nov; 72(5):1246-57. PubMed ID: 17673570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
    Berry EB; Keelan JA; Helliwell RJ; Gilmour RS; Mitchell MD
    Mol Pharmacol; 2005 Jul; 68(1):169-78. PubMed ID: 15821150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.